Andrew M. Peseski

Andrew M. Peseski

Hematology
100 Duke Health Cary Pl
Cary, NC 27519

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

Journal: Blood advances
Published: May 18, 2026

The complexity of "provoked" venous thromboembolism: one treatment plan does not fit all Commentary on the HI-PRO Trial.

The complexity of "provoked" venous thromboembolism: one treatment plan does not fit all Commentary on the HI-PRO Trial.

Journal: Blood advances
Published: May 06, 2026

Anticoagulation in malignancy: the patient who bleeds and clots simultaneously.

Anticoagulation in malignancy: the patient who bleeds and clots simultaneously.

Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025

Qualitative comparison of perioperative anticoagulation management guidelines across US institutions.

Qualitative comparison of perioperative anticoagulation management guidelines across US institutions.

Journal: Thrombosis research
Published: September 24, 2025

Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions.

Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions.

Journal: Thrombosis research
Published: August 09, 2025

Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.

Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.

Journal: Blood advances
Published: November 18, 2024

Multimodal quality improvement project on reducing hospital perioperative thromboembolic events (Patient Safety Indicator-12).

Multimodal quality improvement project on reducing hospital perioperative thromboembolic events (Patient Safety Indicator-12).

Journal: BMJ open quality
Published: June 10, 2024

An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county.

An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county.

Journal: Research and practice in thrombosis and haemostasis
Published: February 22, 2024
Showing 1-8 of 8

Last Updated: 09/26/2026